Vol 7, No 4 (2022)
Review article
Published online: 2022-12-21
Effectiveness of laparoscopic sleeve gastrectomy and one anastomosis gastric bypass on the resolution of metabolic syndrome — a review
1
, 1, 23, 1, 1, 1
, 1, 23, 1, 1, 1
Medical Research Journal 2022;7(4):340-345.
Abstract
The main cause of the development of metabolic syndrome seems to be an imbalance of calorie intake and energy expenditure. However genetic and epigenetic factors, sedentary lifestyle, poor food quality, and disturbances in gut microbiota also play a major role. There is no single effective method of treatment for metabolic syndrome. Dietary therapy and an increase in physical activity along with pharmacological treatment are not fully effective to recommend them as a therapy for metabolic syndrome. Today, modern bariatric-metabolic procedures such as laparoscopic sleeve gastrectomy or single anastomosis gastric bypass give the best chances of successful resolution of metabolic syndrome.
Keywords: sleeve gastrectomyone anastomosis gastric bypassmini gastric bypassobesitymetabolic syndrome
References
- World Health Organization. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (12.04.2022).
- Kushner RF. Weight loss strategies for treatment of obesity: lifestyle management and pharmacotherapy. Prog Cardiovasc Dis. 2018; 61(2): 246–252.
- Hanipah ZN, Schauer PR. Bariatric surgery as a long-term treatment for type 2 diabetes/metabolic syndrome. Annu Rev Med. 2020; 71: 1–15.
- Wojciak PA, Pawłuszewicz P, Diemieszczyk I, et al. Laparoscopic sleeve gastrectomy: a study of efficiency in treatment of metabolic syndrome components, comorbidities and influence on certain biochemical markers. Wideochir Inne Tech Maloinwazyjne. 2020; 15(1): 136–147.
- Jung JJ, Park AK, Hutter MM. The united states experience with one anastomosis gastric bypass at mbsaqip-accredited centers. Obes Surg. 2022; 32(10): 3239–3247.
- Han Y, Jia Y, Wang H, et al. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies. Int J Surg. 2020; 76: 101–110.
- Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018; 20(2): 12.
- Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183: 109119.
- Rodríguez JE, Campbell KM. Racial and ethnic disparities in prevalence and care of patients with type 2 diabetes. Clin Diabetes. 2017; 35(1): 66–70.
- Stierman B, Afful J, Carroll M, et al. National Health and Nutrition Examination Survey 2017–March 2020 Pre-pandemic Data Files. Natl Health Stat Rep. 2021(158): 1–20.
- Eurostat Data Browser. https://ec.europa.eu/eurostat/databrowser/view/hlth_ehis_bm1e/default/table?lang=en (12.04.2022).
- Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640–1645.
- Després JP. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J Suppl. 2006; 8(suppl_B): B4–B12.
- Zafar U, Khaliq S, Ahmad HU, et al. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens). 2018; 17(3): 299–313.
- Bleker LS, de Rooij SR, Painter RC, et al. Cohort profile: the Dutch famine birth cohort (DFBC)— a prospective birth cohort study in the Netherlands. BMJ Open. 2021; 11: e042078.
- Qian Y, Xu H, Wang Y, et al. Obstructive sleep apnea predicts risk of metabolic syndrome independently of obesity: a meta-analysis. Arch Med Sci. 2016; 12(5): 1077–1087.
- Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022; 46(1): 15–37.
- Kwon HJ, Pessin JE. 39 Insulin‐Mediated PI3K and AKT Signaling. In: Arias IME, Alter HJ, Boyer JL, Cohen DE, Shafritz A, Thorgeirsson SS, Wolkoff AW. ed. The Liver: Biology and Pathobiology, 6th Edition. Wiley Blackwell, Hoboken 2020: 485–495.
- Zafar U, Khaliq S, Ahmad HU, et al. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens). 2018; 17(3): 299–313.
- Głuszyńska P, Lemancewicz D, Dzięcioł JB, et al. Non-alcoholic fatty liver disease (NAFLD) and bariatric/metabolic surgery as its treatment option: a review. J Clin Med. 2021; 10(24): 5721.
- Wu D, Wang H, Xie L, et al. Cross-talk between gut microbiota and adipose tissues in obesity and related metabolic diseases. Front Endocrinol (Lausanne). 2022; 13: 908868.
- Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Sci Med Rehabil. 2018; 10: 7.
- Izquierdo AG, Crujeiras AB, Casanueva FF, et al. Leptin, obesity, and leptin resistance: where are we 25 years later? Nutrients. 2019; 11(11): 2704.
- Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019; 393(10178): 1299–1309.
- World Health Organization. Physical activity. https://www.who.int/news-room/fact-sheets/detail/physical-activity (12.04.2022).
- Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Sci Med Rehabil. 2018; 10: 7.
- Lei XG, Ruan JQ, Lai C, et al. Efficacy and safety of phentermine/topiramate in adults with overweight or obesity: a systematic review and meta-analysis. Obesity (Silver Spring). 2021; 29(6): 985–994.
- Montan PD, Sourlas A, Olivero J, et al. Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Ann Transl Med. 2019; 7(16): 393.
- Konwar M, Bose D, Jaiswal SK, et al. Efficacy and safety of liraglutide 3.0 mg in patients with overweight and obese with or without diabetes: a systematic review and meta-analysis. Int J Clin Pract. 2022; 2022: 1201977.
- Diemieszczyk I, Głuszyńska P, Gołaszewski P, et al. The effect of laparoscopic sleeve gastrectomy on body mass index and obesity-related diseases in patients over 50 years old. Medical Research Journal. 2022; 7(1): 61–65.
- Grönroos S, Helmiö M, Juuti A, et al. Effect of laparoscopic sleeve gastrectomy vs roux-en-y gastric bypass on weight loss and quality of life at 7 years in patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg. 2021; 156(2): 137–146.
- Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014; 24(9): 1552–1562.
- Woźniewska P, Diemieszczyk I, Groth D, et al. The influence of patient's age on metabolic and bariatric results of laparoscopic sleeve gastrectomy in 2-year observation. BMC Surg. 2020; 20(1): 323.
- Martini F, Iannelli A, Treacy P, et al. Perioperative complications of sleeve gastrectomy: review of the literature. J Minim Access Surg. 2019; 15(1): 1–7.
- Głuszyńska P, Diemieszczyk I, Szczerbiński Ł, et al. Risk factors for early and late complications after laparoscopic sleeve gastrectomy in one-year observation. J Clin Med. 2022; 11(2): 436.
- Kheirvari M, Dadkhah Nikroo N, Jaafarinejad H, et al. The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. Heliyon. 2020; 6(2): e03496.
- Musella M, Bruni V, Greco F, et al. Conversion from laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) to one anastomosis gastric bypass (OAGB): preliminary data from a multicenter retrospective study. Surg Obes Relat Dis. 2019; 15(8): 1332–1339.
- Hutch CR, Sandoval D. The role of GLP-1 in the metabolic success of bariatric surgery. Endocrinology. 2017; 158(12): 4139–4151.
- Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Metabolic and endocrine consequences of bariatric surgery. Front Endocrinol (Lausanne). 2019; 10: 626.
- Stoica L, Dobrescu A, Isaic A, et al. Metabolic and hormonal changes after sleeve gastrectomy and mini gastric bypass in a rat model of induced type 2 diabetes mellitus and obesity. Chirurgia (Bucur). 2019; 114(6): 732–738.
- Browning MG, Pessoa BM, Khoraki J, et al. Changes in bile acid metabolism, transport, and signaling as central drivers for metabolic improvements after bariatric surgery. Curr Obes Rep. 2019; 8(2): 175–184.
- Dong TS, Gupta A, Jacobs JP, et al. Improvement in uncontrolled eating behavior after laparoscopic sleeve gastrectomy is associated with alterations in the brain-gut-microbiome axis in obese women. Nutrients. 2020; 12(10): 2924.
- Madadi F, Jawad R, Mousati I, et al. Remission of type 2 diabetes and sleeve gastrectomy in morbid obesity: a comparative systematic review and meta-analysis. Obes Surg. 2019; 29(12): 4066–4076.
- Wölnerhanssen BK, Peterli R, Hurme S, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials (SLEEVEPASS and SM-BOSS). Br J Surg. 2021; 108(1): 49–57.
- Diemieszczyk I, Woźniewska P, Gołaszewski P, et al. Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood pressure? Pol Arch Intern Med. 2021; 131(7-8): 693–700.
- Kaya BC, Elkan H. The impact of weight loss after laparoscopic sleeve gastrectomy on early markers of atherosclerotic vascular disease: a prospective study. Kardiol Pol. 2020; 78(7-8): 674–680.
- Gomes-Rocha SR, Costa-Pinho AM, Pais-Neto CC, et al. CRI-O Group. Roux-en-Y gastric bypass vs sleeve gastrectomy in super obesity: a systematic review and meta-analysis. Obes Surg. 2022; 32(1): 170–185.
- Rutledge R, Kular K, Manchanda N. The mini-gastric bypass original technique. Int J Surg. 2019; 61: 38–41.
- Liagre A, Debs T, Kassir R, et al. One anastomosis gastric bypass with a biliopancreatic limb of 150 cm: weight loss, nutritional outcomes, endoscopic results, and quality of life at 8-year follow-up. Obes Surg. 2020; 30(11): 4206–4217.
- Scavone G, Caltabiano DC, Gulino F, et al. Laparoscopic mini/one anastomosis gastric bypass: anatomic features, imaging, efficacy and postoperative complications. Updates Surg. 2020; 72(2): 493–502.
- Deitel M, Rutledge R. Mini-gastric bypass: prevention and management of complications in performance and follow-up. Int J Surg. 2019; 71: 119–123.
- Zorrilla-Nunez LF, Campbell A, Giambartolomei G, et al. The importance of the biliopancreatic limb length in gastric bypass: a systematic review. Surg Obes Relat Dis. 2019; 15(1): 43–49.
- Felsenreich DM, Langer FB, Eichelter J, et al. Bariatric surgery-how much malabsorption do we need? -A review of various limb lengths in different gastric bypass procedures. J Clin Med. 2021; 10(4): 674.
- Al-Garzaie A, Alqarzaie AA, Al-Zahrani HA, et al. Laparoscopic reversion of one-anastomosis gastric bypass to normal anatomy: case series and literature review. Am J Case Rep. 2022; 23: e936776.
- Deitel M. Essentials of Mini – One Anastomosis Gastric Bypass. Springer, Cham 2018: 32–34.
- Kular KS, Manchanda N, Rutledge R. Physiology of the MGB: How It Works for Long-Term Weight Loss. In: Deitel M. ed. Essentials of Mini ‒ One Anastomosis Gastric Bypass. Springer, Cham 2018.
- Tourky M, Issa M, Salman MA, et al. Nutritional complications after laparoscopic roux-en-y gastric bypass and one-anastomosis gastric bypass: a comparative systematic review and meta-analysis. Cureus. 2022; 14(1): e21114.
- Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019; 393(10178): 1299–1309.
- Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus roux-en-y gastric bypass for morbid obesity: an updated meta-analysis. Obes Surg. 2019; 29(9): 2721–2730.